Early Phase 1 Gastroparesis Trial, Recruiting NCT06803589 Sponsor: Mayo Clinic Condition: Gastroparesis
Back to Gastroparesis

Early Phase 1 Gastroparesis Trial, Recruiting

NCT06803589
Recruiting Early Phase 1

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You have had symptoms for more than 6 months that have not gotten better with standard treatments
  • For those with gastroparesis (a condition where the stomach empties too slowly): your symptom score on a specific questionnaire must be above 21, indicating significant symptoms (confirm with trial site)

Who may not be able to join:

  • You have a known history of growth hormone deficiency, or problems with your hypothalamus or pituitary gland (small glands in the brain)
  • You have diabetes
  • You have previously used growth hormone therapy
  • Your IGF-1 blood levels (a hormone measured in the blood) are low for your age (confirm with trial site)
  • You are a woman currently taking estrogen pills by mouth
  • You are pregnant or currently breastfeeding
  • You have a history of cancerous solid tumors
  • You are considered obese, meaning your body mass index (BMI) is above 30
  • You have a history of heart disease or blood clot-related conditions
  • You have a history of sarcoidosis (an inflammatory disease affecting multiple organs)
  • You have previously had surgery on your pituitary gland
  • You have a history of thyroid nodules (lumps on the thyroid gland in your neck)
  • You have any other condition that the trial doctor believes would prevent you from completing the study
  • You are unwilling or unable to give your informed consent to participate

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
Early Phase 1 studies are small, early exploratory studies that come before the main Phase 1 to 3 testing, so a standard phase success rate does not apply.

Contact this trial

Principal Investigator: Tisha Lunsford, Mayo Clinic

Phone: 480-301-4679

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Early Phase 1
Sponsor
Registry
ClinicalTrials.gov
Start date
22 October 2024
Est. completion
1 October 2027

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Gastroparesis Cardinal Symptom Index (GCSI)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov